Hideaki Kusaka

1.3k total citations
36 papers, 1.1k citations indexed

About

Hideaki Kusaka is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hideaki Kusaka has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hideaki Kusaka's work include Adenosine and Purinergic Signaling (16 papers), Acute Kidney Injury Research (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hideaki Kusaka is often cited by papers focused on Adenosine and Purinergic Signaling (16 papers), Acute Kidney Injury Research (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hideaki Kusaka collaborates with scholars based in Japan, United States and Singapore. Hideaki Kusaka's co-authors include Akira Karasawa, Stevan P. Tofovic, Shiro Akinaga, Sheldon Bastacky, Edwin K. Jackson, Yoshinori Yamashita, Kozo Yao, Curtis K. Kost, Ken Nagashima and Kiyoshi Sato and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Clinical Cancer Research.

In The Last Decade

Hideaki Kusaka

36 papers receiving 1.1k citations

Peers

Hideaki Kusaka

PHYSI

CCM

GENET

Mauro Torti Italy

Tsugumichi Saito Japan

De‐Long Hao China

Gina M. Warner United States

Cyndi R. Morales United States

Germano Baj Italy

Bertrand Toutain France

Douglas J. Franks Canada

Yariv Kanfi Israel

Hasan Mahmud Germany

Mauro Torti Italy

Hideaki Kusaka

492 ×1.0

78 ×0.3

PHYSI

240 ×1.1

PHYSI

242 ×1.9

CCM

93 ×0.8

GENET

Citations per year, relative to Hideaki Kusaka Hideaki Kusaka (= 1×) peers Mauro Torti

Countries citing papers authored by Hideaki Kusaka

Since Specialization

Citations

This map shows the geographic impact of Hideaki Kusaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Kusaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Kusaka more than expected).

Fields of papers citing papers by Hideaki Kusaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Kusaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Kusaka. The network helps show where Hideaki Kusaka may publish in the future.

Co-authorship network of co-authors of Hideaki Kusaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Kusaka. A scholar is included among the top collaborators of Hideaki Kusaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Kusaka. Hideaki Kusaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kunisato, Atsushi, et al.. (2014). Detection of Thalidomide Embryotoxicity by In Vitro Embryotoxicity Testing Based on Human iPS Cells. Journal of Pharmacological Sciences. 124(2). 201–207. 21 indexed citations

Sugimoto, Yoshiyuki, et al.. (2011). Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker. Life Sciences. 88(19-20). 898–907. 10 indexed citations

Shimada, Naoki, Toshihiko Ishii, Hideaki Kusaka, et al.. (2008). A neutralizing anti‐fibroblast growth factor (FGF) 8 monoclonal antibody shows anti‐tumor activity against FGF8b‐expressing LNCaP xenografts in androgen‐dependent and ‐independent conditions. The Prostate. 68(6). 640–650. 31 indexed citations

Mori, Kiyotoshi, Yoshimitsu Katoh, Hiroshi Yano, et al.. (2005). Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256. European Journal of Pharmacology. 528(1-3). 176–182. 1 indexed citations

Karasawa, Akira, et al.. (2004). Adenosine uptake inhibitors. European Journal of Pharmacology. 495(1). 1–16. 62 indexed citations

Nakamachi, Yuji, M. Koshiba, Takashi Nakazawa, et al.. (2003). Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis & Rheumatism. 48(3). 668–674. 55 indexed citations

Karasawa, Akira, et al.. (2003). Pharmacological study on the effects of the adenosine uptake inhibitor KF24345 on inflammatory diseases.. Folia Pharmacologica Japonica. 122(2). 121–134. 1 indexed citations

Sano, Junichi, et al.. (2002). Adenosine Uptake Inhibition Ameliorates Cerulein-Induced Acute Pancreatitis in Mice. Pancreas. 25(4). 387–392. 8 indexed citations

Sato, Hitoshi, et al.. (2002). Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice. European Journal of Pharmacology. 449(3). 293–300. 8 indexed citations

10.

Takayama, Makoto, et al.. (2002). KF24345, an Adenosine Uptake Inhibitor, Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Leukopenia via Endogenous Adenosine in Mice. Journal of Pharmacology and Experimental Therapeutics. 300(1). 200–205. 31 indexed citations

11.

Tofovic, Stevan P., Hideaki Kusaka, Edwin K. Jackson, & Sheldon Bastacky. (2001). RENAL AND METABOLIC EFFECTS OF CAFFEINE IN OBESE (fa/fa^cp), DIABETIC, HYPERTENSIVE ZSF1 RATS^*. Renal Failure. 23(2). 159–173. 17 indexed citations

12.

Tofovic, Stevan P., Hideaki Kusaka, Curtis K. Kost, & Sheldon Bastacky. (2000). RENAL FUNCTION AND STRUCTURE IN DIABETIC, HYPERTENSIVE, OBESE ZDFxSHHF-HYBRID RATS. Renal Failure. 22(4). 387–406. 66 indexed citations

13.

Tofovic, Stevan P., Hideaki Kusaka, Ping Li, & Edwin K. Jackson. (1998). Effects of Adenosine Deaminase Inhibition on Blood Pressure in Old Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension. 20(3). 329–344. 21 indexed citations

14.

Tofovic, Stevan P., et al.. (1996). Central Effects of Caffeine on Renal Renin Secretion and Norepinephrine Spillover. Journal of Cardiovascular Pharmacology. 28(2). 302–313. 19 indexed citations

15.

Nagashima, Ken, Hideaki Kusaka, & Akira Karasawa. (1995). Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, against Cisplatin-Induced Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 67(4). 349–358. 30 indexed citations

16.

Kusaka, Hideaki, Ken Nagashima, & Akira Karasawa. (1995). Effects of KW-3902, an Adenosine A1-Receptor Antagonist, on Ascites Volume in Puromycin Aminonucleoside (PAN)-Induced Nephrotic Rats. The Japanese Journal of Pharmacology. 68(2). 213–216. 4 indexed citations

17.

Nomura, Hiroko, et al.. (1995). Antihypertensive Effects of KW-3902, an Adenosine A1-Receptor Antagonist, in Dahl Salt-Sensitive Rats. The Japanese Journal of Pharmacology. 68(4). 389–396. 13 indexed citations

18.

Nagashima, Ken, Hideaki Kusaka, Kiyoshi Sato, & Akira Karasawa. (1994). Effects of KW-3902, a Novel Adenosine A1-Receptor Antagonist, on Cephaloridine-Induced Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 64(1). 9–18. 21 indexed citations

19.

Yao, Kozo, Hideaki Kusaka, Kiyoshi Sato, & Akira Karasawa. (1994). Protective Effects of KW-3902, a Novel Adenosine Al-Receptor Antagonist, against Gentamicin-Induced Acute Renal Failure in Rats.. The Japanese Journal of Pharmacology. 65(2). 167–170. 22 indexed citations

20.

Yamagata, T., Tatsuya Kobayashi, Hideaki Kusaka, & Akira Karasawa. (1994). Diuretic Effects of KW-3902, a Novel Adenosine A1-Receptor Antagonist, in Anesthetized Dogs.. Biological and Pharmaceutical Bulletin. 17(12). 1599–1603. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact